1.0 jean-françois delfraissy intro
-
Upload
association-lir -
Category
Health & Medicine
-
view
571 -
download
1
description
Transcript of 1.0 jean-françois delfraissy intro
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
1CEA CHRU
CNRS CPU INRA
INRIA INSERM
INSTITUT PASTEUR
IRD
3rd International Research MeetingJune 10th, 2011, Hôtel Marigny
Introduction
Pr Jean-François Delfraissy
Institut de Microbiologie et Maladies Infectieuses (IMMI)
Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)
CHU Bicetre – Paris XI
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
2
% of deaths18%
15%
31%
36%PneumoniaDiarrhoeaOther infectionsNon infectious
Infectious diseases account for 26% of all deaths worldwide
Leading cause of mortality in ressources limited countries
Two-thirds of worldwide deaths
in children <5 years old
The Heavy Burden of Infectious Diseases
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
« Emergence »: a global threat
Vectors
Hosts
Humans
• Newly apparent pathogens: HIV, Ebola, H5N1, H1N1…
• Rapidly increasing in incidence or geographic range : dengue,
chikungunya, West Nile
• Multidrug Resistant Pathogens :
NDM-1, E.Coli (EHEC)
• Importance of zoonosis
→Multidisciplinary approach
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
A new vision of microbiology
• Discovery of new viruses, new bacteria
• The commensal microbiota : from homeostasis to disease
• New technologies : deep sequencing, omics…
• Molecular basis of host defense
• Host genetic control
• Biomarkers, Point of care, Pharmacogenomics
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
Medical and Scientific challenges
• Transmission of infection (mechanisms, nosocomial…)
• Emerging diseases; zoonosis, human ecology, biodiversity
• Resistance : Tuberculosis, Bacteria, MDR…
• Infectious agents and non infectious diseases: cancer,
cardiovascular, obesity, allergy, inflammation,…
• Vaccination: new vaccines, immunity, SHS…
• The big 3 : HIV, Tuberculosis, Malaria
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
IMMI: French Biomedical research Centers
Institut Pasteur ParisPitié SalpétrièreMondor/Bicêtre/Orsay/CEA/SaclayBichat/St LouisCochin/Cordeliers
BIOPOLE Lyon-Grenoble IRT Lyon/Pasteur
Institut Pasteur Lille
Bordeaux
Strasbourg
INFECTIOPOLE SudMarseille-Montpellier-NiceIHU
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
Microbiology and Infectious DiseasesKey points: France 2011
• Major Institutions : Institut Pasteur, Inserm, CNRS, IRD
• Others : ANRS, CEA, CIRAD, INRA, INVS, Universities
• 12% of French research forces: 300 teams, 2000 Scientists & Technical staff
• 18% of French biomedical publications: 5000 publications per year
• Translationnal and clinical research: 35 clinical units involved, including HIV and hepatits
• Network of vaccine research centers
• Large research network in ressources limited countries
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
Scientific Program (1)
8.55 -11.30
• Session 1: UNDERSTANDING INFECTIOUS DISEASES: NEW
MECHANISMS & PARADIGMS
• Session 2: NEW TARGETS AND TOOLS IN INFECTIOLOGY
11.30 Transfer to Elysée Palace
12.15 The President Sarkozy Lecture
12.45 – 13.45 Buffet-Lunch
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
Scientific Program (2)
14.00 – 14.30 • Session 3: NORTH-SOUTH PARTNERSHIPS:
POWERFUL RESEARCH TOOLS
14.30 – 17.00 R&D Dating Session :
Twenty one companies will meet successively with 4 scientific teams representatives
This very short meeting allows to define whether a future in depth meeting should be scheduled in case of confirmed common interests
17.15 Conclusion remarks: Pierre TEILLAC – Chairman of ARIIS
17.45 Allocution by the Minister Mr Eric BESSON